Literature DB >> 16174756

FcepsilonR1 and toll-like receptors mediate synergistic signals to markedly augment production of inflammatory cytokines in murine mast cells.

Huihong Qiao1, Marcus V Andrade, Felipe A Lisboa, Katrina Morgan, Michael A Beaven.   

Abstract

Mast cells mediate both IgE-dependent allergic reactions and protective responses against acute infections, possibly through the activation of Toll-like receptors (TLRs). We find that antigen interacts synergistically with TLR2 and TLR4 ligands to markedly enhance production of cytokines in murine mast cell lines. However, the TLR ligands neither stimulated degranulation and release of arachidonic acid nor influenced such responses to antigen, probably because these ligands failed to generate a necessary calcium signal. The enhanced cytokine production could be attributed to synergistic activation of mitogen-activated protein kinases in addition to the engagement of a more effective repertoire of transcription factors for cytokine gene transcription. The synergistic interactions of TLR ligands and antigen might have relevance to the exacerbation of IgE-mediated allergic diseases by infectious agents.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16174756      PMCID: PMC1895616          DOI: 10.1182/blood-2005-06-2271

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  65 in total

Review 1.  Endotoxin exposure in allergy and asthma: reconciling a paradox.

Authors:  Andrew H Liu
Journal:  J Allergy Clin Immunol       Date:  2002-03       Impact factor: 10.793

Review 2.  Endotoxin-stimulated innate immunity: A contributing factor for asthma.

Authors:  C E Reed; D K Milton
Journal:  J Allergy Clin Immunol       Date:  2001-08       Impact factor: 10.793

Review 3.  Partners in transcription: NFAT and AP-1.

Authors:  F Macián; C López-Rodríguez; A Rao
Journal:  Oncogene       Date:  2001-04-30       Impact factor: 9.867

4.  SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase.

Authors:  B L Bennett; D T Sasaki; B W Murray; E C O'Leary; S T Sakata; W Xu; J C Leisten; A Motiwala; S Pierce; Y Satoh; S S Bhagwat; A M Manning; D W Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

Review 5.  Signaling through the JAK/STAT pathway, recent advances and future challenges.

Authors:  T Kisseleva; S Bhattacharya; J Braunstein; C W Schindler
Journal:  Gene       Date:  2002-02-20       Impact factor: 3.688

6.  Toll-like receptor 4-mediated activation of murine mast cells.

Authors:  J D McCurdy; T J Lin; J S Marshall
Journal:  J Leukoc Biol       Date:  2001-12       Impact factor: 4.962

Review 7.  Mast cells in the development of adaptive immune responses.

Authors:  Stephen J Galli; Susumu Nakae; Mindy Tsai
Journal:  Nat Immunol       Date:  2005-02       Impact factor: 25.606

8.  Differential responses of mast cell Toll-like receptors 2 and 4 in allergy and innate immunity.

Authors:  Volaluck Supajatura; Hiroko Ushio; Atsuhito Nakao; Shizuo Akira; Ko Okumura; Chisei Ra; Hideoki Ogawa
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

9.  Involvement of toll-like receptor 4 in innate immunity to respiratory syncytial virus.

Authors:  L M Haynes; D D Moore; E A Kurt-Jones; R W Finberg; L J Anderson; R A Tripp
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

10.  Variable expression of Toll-like receptor in murine innate and adaptive immune cell lines.

Authors:  Steven E Applequist; Robert P A Wallin; Hans-Gustaf Ljunggren
Journal:  Int Immunol       Date:  2002-09       Impact factor: 4.823

View more
  68 in total

1.  IL-10-induced gp130 expression in mouse mast cells permits IL-6 trans-signaling.

Authors:  Daniel Traum; Patricia Timothee; Jonathan Silver; Stefan Rose-John; Matthias Ernst; David F LaRosa
Journal:  J Leukoc Biol       Date:  2011-12-02       Impact factor: 4.962

2.  Toll-like receptors participate in macrophage activation and intracellular control of Leishmania (Viannia) panamensis.

Authors:  Carolina Gallego; Douglas Golenbock; Maria Adelaida Gomez; Nancy Gore Saravia
Journal:  Infect Immun       Date:  2011-04-25       Impact factor: 3.441

Review 3.  Mast cells and inflammation.

Authors:  Theoharis C Theoharides; Konstantinos-Dionysios Alysandratos; Asimenia Angelidou; Danae-Anastasia Delivanis; Nikolaos Sismanopoulos; Bodi Zhang; Shahrzad Asadi; Magdalini Vasiadi; Zuyi Weng; Alexandra Miniati; Dimitrios Kalogeromitros
Journal:  Biochim Biophys Acta       Date:  2010-12-23

Review 4.  G protein-coupled receptors and the modification of FcepsilonRI-mediated mast cell activation.

Authors:  Hye Sun Kuehn; Alasdair M Gilfillan
Journal:  Immunol Lett       Date:  2007-09-18       Impact factor: 3.685

Review 5.  Molecular regulation of mast cell development and maturation.

Authors:  Chenxiong Liu; Zhigang Liu; Zhilong Li; Yaojiong Wu
Journal:  Mol Biol Rep       Date:  2009-07-31       Impact factor: 2.316

6.  IgE signaling suppresses FcepsilonRIbeta expression.

Authors:  Jennifer Brenzovich; Matthew Macey; Josephine Fernando; Hey Jin Chong; Brian Barnstein; Paria Mirmonsef; Johanna K Morales; Akiko Kimura; Tracey Dawson Cruz; John J Ryan
Journal:  J Leukoc Biol       Date:  2009-09-09       Impact factor: 4.962

7.  Synergistic activation of phospholipases Cgamma and Cbeta: a novel mechanism for PI3K-independent enhancement of FcepsilonRI-induced mast cell mediator release.

Authors:  Hye Sun Kuehn; Michael A Beaven; Hong-Tao Ma; Mi-Sun Kim; Dean D Metcalfe; Alasdair M Gilfillan
Journal:  Cell Signal       Date:  2008-01-22       Impact factor: 4.315

8.  IL-33 induces a hyporesponsive phenotype in human and mouse mast cells.

Authors:  Mi-Yeon Jung; Daniel Smrž; Avanti Desai; Geethani Bandara; Tomonobu Ito; Shoko Iwaki; Jeong-Han Kang; Marcus V Andrade; Susana C Hilderbrand; Jared M Brown; Michael A Beaven; Dean D Metcalfe; Alasdair M Gilfillan
Journal:  J Immunol       Date:  2012-12-17       Impact factor: 5.422

9.  Prevention of F-actin assembly switches the response to SCF from chemotaxis to degranulation in human mast cells.

Authors:  Daniel Smrž; Geethani Bandara; Michael A Beaven; Dean D Metcalfe; Alasdair M Gilfillan
Journal:  Eur J Immunol       Date:  2013-06-04       Impact factor: 5.532

Review 10.  Amplification mechanisms for the enhancement of antigen-mediated mast cell activation.

Authors:  Alasdair M Gilfillan; Richard D Peavy; Dean D Metcalfe
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.